• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1994 Fiscal Year Final Research Report Summary

Serum anti-phospholipid antibodies in patients with multiple sclerosis

Research Project

Project/Area Number 05670566
Research Category

Grant-in-Aid for General Scientific Research (C)

Allocation TypeSingle-year Grants
Research Field Neurology
Research InstitutionFukushima Medical College

Principal Investigator

YAMAMOTO Teiji  Fukushima Medical College, Dept.Neurology, Professor, 医学部, 教授 (10106487)

Co-Investigator(Kenkyū-buntansha) SAITO Tasuku  Fukushima Medical College, Dept.Neurology, Instructor, 医学部, 助手 (20215544)
TSUKAMOTO Tetsuro  Fukushima Medical College, Dept.Neurology, Associate Professor, 医学部, 助教授 (20171978)
Project Period (FY) 1993 – 1994
Keywordsmultiple sclerosis / anti-phospholipid antibodies / 2-glycoprotein I
Research Abstract

We have measured serum antiphospholipid antibodies (aPL) in patients with multiple sclerosis (MS) using enzyme linked immunosorbent assey and examined the correlations between these antibodies and MS.This study included thirty-two patients with clinically definite MS,thirteen patients with other autoimmune neurological disease excluding collagen vascular diseases (disease control.A) , eight patients with collagen vascular diseases (disease control.B) and twenty-six healthy persons (normal control) . In MS group IgG antibody against cardiolipin (CL) was detected in 3 (9%) ; anti-CL antibody showed cofactor (2-glycoprotein I) dependency in 2 but one was cofactor independent. IgM antibody was elevated in 14 of 32 patients (449%) with MS,but cofactor dependency was not determined. However, this was significantly higer in frequecy than that of the disease control A (P<0.01) and normal control (P<0.01) . Each anti-CL IgG antibody purified from four patients had differed reactivities against DNA.In addition, the APLA positive group in MS possessed at higer rate of other autoantibodies such as antinuclear antibody than the negative group. However, clinically two groups of MS were indistinguishable. The higher incidence of APLA imply that a broad spectrum of autoantibodies might be produced in MS ; some antibodies presumably related directly to MS pathogenesis are yet to be identified but APLA might be one of those antibodies which are to be tested for the capability of central inflammation and demyelination.

  • Research Products

    (1 results)

All Other

All Publications (1 results)

  • [Publications] T.Sugiyama, T.Yamamoto: "SERUM ANTI-PHOSPHOLIPID ANTIBODIES IN PATIENTS WITH MULTIPLE SCLEROSIS" Tohoku J Exp Med.(in press).

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 1996-04-15  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi